Tuesday's Twitter Chat Round Up

Thank you to everyone who participated in Tuesday's Twitter Chat. There was a lot of great discussion, sharing and learning. If you missed the chat you can catch the highlights here: https://storify.com/theNPSF/patient-safety-awareness-week-58c845cb3b89056c3ac355cb

Even though the Twitter Chat is over the sharing can continue. Have thoughts on these topics? Comment below and keep the conversation going.

Communication: What are the greatest areas of risk for communication breakdowns and ways to improve communication between clinicians and patients/families to improve safety?

Medication Safety: What steps do clinicians take to prevent medication errors? What steps should patients and families take to ensure safe use of medications? How does technology help or hinder medication safety?

Patient Engagement, Patient Experience, and Patient Safety: What is the difference between patient engagement and patient experience of care? How do they differ and where are the overlaps?

Patient Safety Past and Future: What should the future of the patient safety field look like in order to accelerate progress? How do you hope things will have improved in the next 5 or 10 years?


Showing 1 reaction

Please check your e-mail for a link to activate your account.

Discussion Forum

No Place Like Home: Advancing the Safety of Care in the Home
Caring for patients in their homes holds many potential benefits, yet the safety of care provided in the home has not...
Improving Services for Children with Behavioral Health Needs
Nationally, there is a critical shortage of mental health practitioners, especially for children. Families come to th...
No One Is Free from Harm
Modern Healthcare recently interviewed health professionals about their own experiences with adverse medical events a...
See All Stories

Patient Safety News

See More News

Twitter: #PSAW18

The Institute for Healthcare Improvement salutes Mallinckrodt Pharmaceuticals for their generous support of this year's Patient Safety Awareness Week.